Clinical Trial Update: FTT PET/CT in Metastatic Prostate Cancer

View source ↗

Summary

A Penn Medicine trial is recruiting to evaluate FTT PET/CT imaging in metastatic prostate cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: Abramson Cancer Center at Penn Medicine | Conditions: Prostate Cancer Metastatic | Status: RECRUITING